These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 4399649

  • 1. [Experience with a compound preparation in the treatment of cerebral blood circulation disorders in practice].
    Bremer C.
    Z Allgemeinmed; 1970 Mar 31; 46(9):478-9. PubMed ID: 4399649
    [No Abstract] [Full Text] [Related]

  • 2. [Treatment of cerebral circulation disorders].
    Brinkmann G, Guthy H, Hildgen J.
    Dtsch Med J; 1969 Dec 20; 20(24):247-9. PubMed ID: 4394415
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Effect of a combination of vasoactive substances on metabolism and the rheoencephalogram].
    Hammerl H, Kränzl C, Nebosis G, Pichler O, Studlar M.
    Wien Klin Wochenschr; 1973 Sep 15; 123(37):533-8. PubMed ID: 4148002
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Vasoactive combination treatment in cerebrovascular sclerosis].
    Klein K.
    Wien Med Wochenschr; 1973 Jan 06; 123(1):14-8. PubMed ID: 4405190
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Experience with the medical treatment of chronic cerebrovascular insufficiency: bamethan and inositol nicotinate versus placebo].
    Cucinotta D, Silvestrini C, Mancini M, Maini C, Passeri M.
    G Clin Med; 1981 May 06; 62(5):339-50. PubMed ID: 6115790
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Comparative effects of sodium nicotinate and dihydroergotamine on cerebral circulation. Rheographic studies in subjects with cerebral vascular diseases].
    Arrigo F, Turiano S, Consolo F.
    Boll Soc Ital Biol Sper; 1973 Mar 15; 49(5):292-7. PubMed ID: 4786565
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Preliminary study on the effect of a nicergoline composition (F.I. 6714) on cerebral blood flow].
    Prencipe M, Cecconi V, Pisarri F.
    Farmaco Prat; 1974 May 15; 29(5):278-84. PubMed ID: 4152517
    [No Abstract] [Full Text] [Related]

  • 16. [Wallerox increases cerebral circulation and heart capacity].
    Heynen U.
    Z Allgemeinmed; 1971 Dec 10; 47(34):1823-5. PubMed ID: 5003212
    [No Abstract] [Full Text] [Related]

  • 17. [Mental effects of Wallerox therapy in the aged].
    Thomae H.
    Med Klin; 1970 Jun 05; 65(23):1132-4. PubMed ID: 5000216
    [No Abstract] [Full Text] [Related]

  • 18. [Therapy of cerebrovascular disorders with Theo-Hexanicit].
    Schoger GA.
    Med Monatsschr; 1971 Dec 05; 25(12):571-3. PubMed ID: 4400544
    [No Abstract] [Full Text] [Related]

  • 19. [Cerebral circulation. Possibilities of drug influence].
    Naess K.
    Tidsskr Nor Laegeforen; 1967 Nov 15; 87(22):1916-8. PubMed ID: 5590460
    [No Abstract] [Full Text] [Related]

  • 20. [Treatment of hearing disorders using Cosaldon retard].
    Schwertdtfeger F.
    Dtsch Med J; 1971 Feb 05; 22(3):87-92. PubMed ID: 5540731
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.